Effects of CAR-T Cell Therapy on Immune Cells and Related Toxic Side Effect Analysis in Patients with Refractory Acute Lymphoblastic Leukemia

Table 3

Comparison of T lymphocyte subsets before and after treatment ().

Groups	CD3+ (%)	CD4+ (%)	CD8+ (%)	CD4+/CD8+ (%)
Before treatment ()
CR+CRi patients treated for 1 month ()	^a	^a		^a
CR+CRi patients treated for 3 months ()	^a	5^a		^ab
PD patients treated for 1 month ()
	4.010	8.340	0.540	8.700
	0.010	<0.001	0.657	<0.001

^a compared with before treatment; ^b compared with CR+CRi patients treated for 1 month.